High-dosage co-amoxiclav in a single dose versus 7 days of co-trimoxazole as treatment of uncomplicated lower urinary tract infection in women
Abstract
The efficacy and adverse event profile of a single 3.25 g dose of co-amoxiclav as treatment of acute uncomplicated lower urinary tract infection in women was compared with that of co-trimoxazole 960 mg bd for 7 days in a prospective, randomized, double-blind multicentre clinical trial. Of the 666 pa …
Keywords
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
humans
pubmed abstract
nih
national institutes of health
national library of medicine
research support
non-u.s. gov't
adult
female
adolescent
aged
middle aged
Drug Administration Schedule
Prospective Studies
Clinical Trial
Randomized Controlled Trial
Double-Blind Method
Multicenter Study
drug therapy
trimethoprim
amoxicillin / administration & dosage
combination / administration & dosage
combination / therapeutic use*
sulfamethoxazole drug combination / therapeutic use*
sulfamethoxazole drug combination / adverse effects
amoxicillin-potassium clavulanate combination
combination / adverse effects
urinary tract infections / microbiology
urinary tract infections / drug therapy*
amoxicillin / therapeutic use
r g masterton
pmid:7768760
doi:10.1093/jac/35.1.129
j a bochsler
amoxicillin / adverse effects
clavulanic acids / administration & dosage
clavulanic acids / adverse effects
clavulanic acids / therapeutic use
sulfamethoxazole drug combination / administration & dosage
Access
Citation
ID:
266750
References
Blockchain Verification
Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
266750
Unique Identifier:
Network:
Scimatic Chain (ID: 481)
Loading...
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
Creates 1,000,000 NFT tokens for this article
Token Features:
- ERC-1155 Standard NFT
- 1 Million Supply per Article
- Transferable via MetaMask
- Permanent Blockchain Record
Scan with Saymatik Web3.0 Wallet